July 21 2022
Population Council Acquires the Monthly Dapivirine Ring and Other Woman-centered HIV Prevention Technologies from the International Partnership for Microbicides

IPM and the Council aim to ensure a sustainable future for the ring program and expand women’s prevention choices SILVER SPRING, Md. (July 21, 2022)—The Population Council, a global nonprofit... More »
March 11 2022
South Africa Approves Dapivirine Vaginal Ring for Use by Women

First long-acting HIV prevention product designed specifically for womenApproval paves the way for the monthly ring’s introduction Nearly two-thirds of new adult HIV infections in South Africa occur... More »
March 8 2022
On International Women’s Day, Let’s #BreaktheBias in HIV/AIDS by Putting Women’s Voices Front and Center

March 8, 2022—This International Women’s Day, we are reflecting on what it takes to #BreakTheBias when it comes to women’s sexual and reproductive health and rights. For decades, women have borne the... More »
February 15 2022
Adolescent girls and young women can and will use HIV prevention products: Results from CROI 2022

      February 15, 2022—Results from the “choice period” of REACH, an open-label study of IPM’s monthly dapivirine ring and daily oral PrEP, were presented today at the 2022 Conference on... More »
January 2022
In vitro drug release, mechanical performance and stability testing of a custom silicone elastomer vaginal ring releasing dapivirine and levonorgestrel

Murphy DJ, Bashi YHD, McCoy C, Boyd P, Brown L, Martin F, McMullen N, Kleinbeck K, Dangi B, Spence P, Hansraj B, Devlin B, Malcolm RK. Int J Pharm X. 2022 Dec; 4: 100112. doi.org/10.1016/j.ijpx.2022.... More »